Company intelligence
CureDuchenne
Together, we WILL cure Duchenne!
About CureDuchenne
CureDuchenne is the global leader in Duchenne research, patient care and innovation. We are committed to improving the lives of those affected by Duchenne through accelerating research, improving care and empowering the community. We won't stop until everyone has a cure. cureduchenne.org Founded by Paul and Debra Miller in 2003, after their son was diagnosed with the disease, CureDuchenne combines fundraising and venture philanthropy leveraging donor dollars to maximize support for promising research into effective treatments for those suffering from Duchenne. With transparency as a core value, investment proceeds are redeployed to support research and other mission critical programs to find a cure.
Verified activity
Signals from CureDuchenne
3 published signals
Legal & Regulatory
CureDuchenne announced that Novartis has accepted the Biologics License Application (BLA) for delpacibart zotadirsen (del-zota) for Priority Review under the Accelerated Approval pathway.
Reported by CureDuchenne
Presence & Recognition
CureDuchenne is hosting a Grandparents Virtual Meetup on September 16
Reported by CureDuchenne
Presence & Recognition
CureDuchenne is hosting the 8th Annual Calves to Cure DMD cattle sale on September 17 in Billings, Montana.
Reported by CureDuchenne